Dapagliflozin in Patients with COVID-19: Truth or Dare

Overview

Journal Lancet Diabetes Endocrinol

Specialty Endocrinology

Date 2021 Jul 24

PMID 34302746

Citations 3

Authors

Xavier Rossello

Francisca Caimari

Affiliations

Soon will be listed here.

Citing Articles

SGLT2 Inhibitors in Long COVID Syndrome: Is There a Potential Role?.

Zimmermann P, Sourij H, Aberer F, Rilstone S, Schierbauer J, Moser O J Cardiovasc Dev Dis. 2023; 10(12).

PMID: 38132646 PMC: 10744331. DOI: 10.3390/jcdd10120478.

Benefits of SGLT2i for the Treatment of Heart Failure Irrespective of Diabetes Diagnosis: A State-of-the-Art Review.

Delgado E, Jodar E, Mezquita-Raya P, Moreno-Perez O Diabetes Ther. 2022; 13(Suppl 1):19-34.

PMID: 35704165 PMC: 9198410. DOI: 10.1007/s13300-022-01278-0.

Hospital management of hyperglycemia in the context of COVID-19: evidence-based clinical considerations.

Mendes T, Camara-de-Souza A, Halpern B Diabetol Metab Syndr. 2022; 14(1):37.

PMID: 35246230 PMC: 8895065. DOI: 10.1186/s13098-022-00808-x.

References

Rodriguez-Leor O, Cid-Alvarez B, de Prado A, Rossello X, Serrador A, Lopez-Palop R . Impact of COVID-19 on ST-segment elevation myocardial infarction care. The Spanish experience. Rev Esp Cardiol (Engl Ed). 2020; 73(12):994-1002. PMC: 7834732. DOI: 10.1016/j.rec.2020.08.002. View

Heerspink H, Stefansson B, Correa-Rotter R, Chertow G, Greene T, Hou F . Dapagliflozin in Patients with Chronic Kidney Disease. N Engl J Med. 2020; 383(15):1436-1446. DOI: 10.1056/NEJMoa2024816. View

Kosiborod M, Esterline R, Furtado R, Oscarsson J, Gasparyan S, Koch G . Dapagliflozin in patients with cardiometabolic risk factors hospitalised with COVID-19 (DARE-19): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Diabetes Endocrinol. 2021; 9(9):586-594. PMC: 8294807. DOI: 10.1016/S2213-8587(21)00180-7. View

Rossello X, Gonzalez-Del-Hoyo M . Survival analyses in cardiovascular research, part I: the essentials. Rev Esp Cardiol (Engl Ed). 2021; 75(1):67-76. DOI: 10.1016/j.rec.2021.06.003. View

Pocock S, Ariti C, Collier T, Wang D . The win ratio: a new approach to the analysis of composite endpoints in clinical trials based on clinical priorities. Eur Heart J. 2011; 33(2):176-82. DOI: 10.1093/eurheartj/ehr352. View